Drug Information Association Logo

The Future of Personalized Medicine and Companion Diagnostics

| Online

« Back to Listing

Overview 

Continuing Education credits are not available for archived webinars
This archive available for purchase through March 31, 2015
Broadcast time: 1 hour 44 minutes


Please note: Due to video use within the presentation, it may take up to 10 minutes to buffer and for the archive to begin playing.


Personalized medicines and companion diagnostics are making it possible to better target drugs so the right drug goes to the right person at the right time. In addition, clinical trials can be made smaller and less costly by restricting them to patients most likely to benefit from the drug. Previously, drugs were developed and tested in a whole population. Now drugs are being developed for specific people so that we don’t give the drug to somebody who’s going to have an adverse event. But how is this new world of personalized medicine regulated?

This webinar will focus on how new product development will look in the future, how it will be regulated, and how it will change the way we practice medicine.

Who Should Attend 

  • Drug Development and R&D Professionals
  • Pharmaceutical and Medical Device and Diagnostics Professionals
  • Regulatory, Clinical and Other Professionals Responsible for Developing Drug/Device Combinations and Companion Diagnostics
  • Regulatory Affairs Professionals

Learning Objectives 

At the conclusion of this webinar, participants should be able to:

  • Identify how personalized medicine and companion diagnostic technologies are used today
  • Discuss current regulatory requirements and how to implement them

Contact Information 

Printable Registration Form

Registration Questions
Customer Service Department
Toll Free: 1.888.257.6457
Phone: +1.215.442.6100
Fax: +1.215.442.6199
CustomerService@diahome.org

Questions about Archived Webinars
Carolyn Callahan
Phone +1.215.442.6158
Fax +1.215.442.6199
Carolyn.Callahan@diahome.org

Technical Requirements 

Click here for minimum system requirements.

Presenter(s) 

Previous Next

Agenda  

Day 1 Thursday, Mar 20, 2014

  • 11:00AM - 12:30PM

    The Future of Personalized Medicine and Companion Diagnostics

    Speaker(s):

    • The Future of Personalized Medicine and Companion Diagnostics
      Michael Drues, PhD
      Founder and President
      Vascular Sciences, United States

Registration Fees 

Other Fees

Group Site
$799.00
Group Plus
$1499.00

Member

Member Government Individual
$125.00
Member Academia Individual
$175.00
Member Individual
$250.00

Non-Member

NonMember Government Individual
$125.00
NonMember Academia Individual
$175.00
NonMember Individual
$350.00
Registration Information

Printable Registration Form

  • Individual registration is a license for ONE internet login allowing one viewer.
  • Group site registration is a license for ONE internet login allowing multiple viewers from one location.
  • Group Plus is a license for up to FIVE internet logins allowing one or more viewers at each login location.

Cancellations:  No refunds will be provided in the event of a participant’s cancellation since all costs for this webinar have been prepaid by DIA. DIA reserves the right to modify or cancel programs and/or substitute presenters or panelists. DIA is not responsible for failure to deliver programs due to circumstances beyond its control.

Participants with Disabilities: Reasonable accommodations will be made available to persons with disabilities who attend an educational activity. Contact the DIA office in writing at least 15 days prior to event to indicate your needs.

Register Online

Unless otherwise disclosed, the statements made by speakers represent their own opinions and not necessarily those of the organization they represent, or that of the Drug Information Association. Speakers, agenda and CE information are subject to change without notice. Recording of any DIA educational material in any type of media is prohibited without prior written consent from DIA.

« Back to Listing
DIA Recommends the Following Related Meetings & Training
Back To Top